IRF4 and hematologic disorder: Consistent with previous findings from Went et al., our results reinforce the role of early B-cell developmental genes such as PAX5 and transcriptional regulators such as BCL11A and IRF4, the latter having pleiotropic effects across multiple hematologic malignancies [44].